FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures
MONDAY, May 21, 2018 -- Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
Doptelet was evaluated in a pair of clinical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Liver | Liver Disease | Pharmaceuticals | Urology & Nephrology